Open AccessDiazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial
Author(s) -
Raja Brauner,
Raphaël Serreau,
Jean–Claude Souberbielle,
Monique Pouillot,
Sophie Grouazel,
Christophe Recasens,
Michel Zérah,
Christian SainteRose,
JeanMarc Tréluyer
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2126
Subject(s) - placebo , medicine , diazoxide , randomized controlled trial , obesity , pediatrics , endocrinology , insulin , alternative medicine , pathology
The objective was to evaluate the safety and efficacy of diazoxide (DZX) for decreasing obesity with hyperinsulinemia in patients treated for hypothalamic-pituitary lesions during childhood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom